These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 229802)

  • 41. Mutants of herpes simplex virus types 1 and 2 that are resistant to phosphonoacetic acid induce altered DNA polymerase activities in infected cells.
    Hay J; Subak-Sharpe JH
    J Gen Virol; 1976 Apr; 31(1):145-8. PubMed ID: 177727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduction of herpes simplex virus-type 2 plaque formation by urea.
    Tumilowicz JJ; Latlief MA
    J Med Virol; 1978; 3(2):151-6. PubMed ID: 215721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trisodium phosphonoformate, a new antiviral compound.
    Helgstrand E; Eriksson B; Johansson NG; Lannerö B; Larsson A; Misiorny A; Norén JO; Sjöberg B; Stenberg K; Stening G; Stridh S; Oberg B
    Science; 1978 Sep; 201(4358):819-21. PubMed ID: 210500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of cytochalasin B on the maturation of herpes simplex virus type 1: an ultrastructural investigation.
    Marciano-Cabral F; Dix RD; Cabral GA; Courtney RJ
    Virology; 1977 Feb; 76(2):860-5. PubMed ID: 190777
    [No Abstract]   [Full Text] [Related]  

  • 45. Aliphatic amines inhibit the formation of syncytia induced by herpes simplex virus type 1.
    Uchida T; Nomura M
    Microbiol Immunol; 1984; 28(2):243-9. PubMed ID: 6145087
    [No Abstract]   [Full Text] [Related]  

  • 46. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
    Charles SJ; Gray JJ
    Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Isolation and characteristics of a mutant herpes simplex virus type 1 resistant to phosphonoacetic acid].
    Gibadulin RA; Denisova TS; Zavgorodniĭ SG; Florent'ev VL; Zhdanov VM
    Vopr Virusol; 1983; 28(4):59-63. PubMed ID: 6314671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Virus-specific changes in mouse cells inoculated with a strain of human cytomegalovirus.
    Gönczöl E; Boldogh I; Váczi L
    Acta Microbiol Acad Sci Hung; 1975; 22(3):275-83. PubMed ID: 168741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.
    Knopf CW
    J Gen Virol; 1987 May; 68 ( Pt 5)():1429-33. PubMed ID: 3033142
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA labeled during phosphonoacetate inhibition and following its reversal in herpesvirus infected cells.
    Jacob RJ
    Arch Virol; 1984; 79(3-4):221-40. PubMed ID: 6320779
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lithium chloride suppresses the synthesis of messenger RNA for infected cell protein-4 and viral deoxyribonucleic acid polymerase in herpes simplex virus-1 infected endothelial cells.
    Ziaie Z; Brinker JM; Kefalides NA
    Lab Invest; 1994 Jan; 70(1):29-38. PubMed ID: 8302016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of nucleoside analogues on the expression of herpes simplex type 1-induced proteins.
    Otto MJ; Lee JJ; Prusoff WH
    Antiviral Res; 1982 Oct; 2(5):267-81. PubMed ID: 6295274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspects of thymidine metabolism and function in cultured mammalian cells infected with herpes simplex virus type 1.
    Baybutt HN; Murray BA; Pearson CK
    J Gen Virol; 1982 Apr; 59(Pt 2):223-34. PubMed ID: 6281368
    [No Abstract]   [Full Text] [Related]  

  • 54. Nuclear accumulation of filamentous herpes simplex virus DNA late during the replicative cycle.
    Luetzeler J; Heine U
    Intervirology; 1978; 10(5):289-99. PubMed ID: 210142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of herpes simplex virus isolated from patients with recurrent herpes keratitis exhibiting "treatment-resistance" to 5-iodo-2'-deoxyuridine.
    Hirano A; Yumura K; Kurimura T; Katsumoto T; Moriyama H; Manabe R
    Acta Virol; 1979 May; 23(3):226-30. PubMed ID: 41435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Involvement of microtubules in cytopathic effects of animal viruses: early proteins of adenovirus and herpesvirus inhibit formation of microtubular paracrystals in HeLa-S3 cells.
    Ebina T; Satake M; Ishida N
    J Gen Virol; 1978 Mar; 38(3):535-48. PubMed ID: 204735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Replication of herpes simplex virus type 1 on hydroxyurea-resistant baby hamster kidney cells.
    Leary K; Bratton J; Francke B
    J Virol; 1983 Jul; 47(1):224-6. PubMed ID: 6306274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reversible inhibition of herpes simplex virus replication by hydroxyurea.
    Rosenkranz HS; Becker Y
    Antimicrob Agents Chemother; 1973 Mar; 3(3):325-31. PubMed ID: 4364174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enrichment of early HSV-induced proteins in phosphonoformate-treated cells.
    Lehtinen MO; Lehtinen TK; Leinikki PO
    Acta Virol; 1984 Jan; 28(1):11-8. PubMed ID: 6143492
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of African swine fever (ASF virus replication by phosphonoacetic acid.
    Moreno MA; Carrascosa AL; Ortín J; Viñuela E
    J Gen Virol; 1978 May; 39(2):253-8. PubMed ID: 650176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.